Thanks Vinnie
Just had a look at the Macquarie report /Update (Target Price reduced to $3.00 and 12 moth target $3.50)
Macquarie have a number of concerns (including existing data being re-presented) but in my opinion - 2 things stood out on the report :
(1) They say cash to run out early next year.
(2) Tweaking of heart failure trial serves to de-risk Teva decision.
Astonishingly and remarkably - similar comments were posted on HC thread by one of the HC posters.
Wow ! !
Its great that HC posters are ahead of the game ...some posters are extremely forward thinking ! Great to have them on board and get a balanced view.
FYI and to all holders - a couple of the other reports & 12 month price targets are as follows:
Macquarie (as above) - Underperform $3.50
Deutsche - Hold $4.50
Credit Suisse - Neutral $4.90
Maxim Group - Buy $14.00
Ladenberg Thalmann - Buy MBLTY(OTC HK) $52.00 ( my estimate in AUS is b/w ~$10-$11).
Good luck to all holders.
Please DYOR and make your own decisions. Good weekend to all.
Thanks Vinnie Just had a look at the Macquarie report /Update...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |